Back to CITADEL ADVISORS LLC CITADEL ADVISORS LLC

AVXLAVXL
Showing 8 of 30 quarters

Position history for CITADEL ADVISORS LLCCITADEL ADVISORS LLC's holdings in ANAVEX LIFE SCIENCES CORP

CITADEL ADVISORS LLC holds 559,435 shares of AVXL (ANAVEX LIFE SCIENCES CORP), worth $1.7M as of 2026-Q1. The position was increased (+391.9% shares). AVXL represents 0.0% of CITADEL ADVISORS LLC's portfolio.

Current Value

$1.7M

Current Shares

559,435

Total Value Change

-$168,191

Total Shares Change

+112,597

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Increased
559,435
+391.9%
$1.7M0.0%$4.69
41
2025-Q4
Decreased
113,739
-41.9%
$404,9110.0%$3.80
0
2025-Q3
Decreased
195,725
-39.3%
$1.7M0.0%$8.65
0
2025-Q2
Increased
322,205
+679x
$3M0.0%$9.48
43
2025-Q1
Decreased
474
-99.8%
$4,0670.0%$8.72
0
2024-Q4
Increased
240,906
+843.8%
$2.6M0.0%$11.04
42
2024-Q3
Decreased
25,525
-94.3%
$144,9820.0%$5.68
0
2024-Q2
Increased
446,838
+111.7Kx
$1.9M0.0%$4.22
42

Other major holders of AVXL: BlackRock, Inc., BlackRock Finance, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used